Divi's Laboratories Limited (DIVISLAB) — FY25 Annual Report | 16 July 2025
Divi's Laboratories announced its 35th Annual General Meeting on July 16, 2025, and confirmed electronic dispatch of the 2024-25 Annual Report to shareholders via newspaper notices in Financial Express and Andhra Prabha.
About Divi's Laboratories Limited (DIVISLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when DIVISLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track DIVISLAB — Free💡 Ask AI about this filing
📊 More DIVISLAB filings
- 🟡 Board Meeting — 10 August 2026 Divi's Laboratories held its 36th AGM on August 10, 2026, via video conferencing, where shareholders...
- 🔴 Financial Results — 6 August 2026 Divi's Laboratories reported consolidated revenue of ₹3,144 crores and profit after tax of ₹902 cror...
- Announcement — 1 August 2026 Divi's Laboratories announced that the audio recording of its Q1 FY27 earnings conference call held ...
- Announcement — 1 August 2026 Divi's Laboratories announced its August 1, 2026 board meeting outcomes, approving unaudited standal...
- 🟡 Board Meeting — 1 August 2026 Divi's Laboratories reported unaudited standalone financial results for Q1 FY2026 ending June 30, 20...
🔥 Also filed on 16 July 2025
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DIVISLAB files new disclosures
Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DIVISLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research